Natco Pharma consolidated net profit rises 5.25% in the March 2025 quarter
Net profit of Natco Pharma rose 5.25% to Rs 406.60 crore in the quarter ended March 2025 as against Rs 386.30 crore during the previous quarter ended March 2024. Sales rose 14.29% to Rs 1221.00 crore in the quarter ended March 2025 as against Rs 1068.30 crore during the previous quarter ended March 2024.
For the full year,net profit rose 35.81% to Rs 1885.40 crore in the year ended March 2025 as against Rs 1388.30 crore during the previous year ended March 2024. Sales rose 10.77% to Rs 4429.50 crore in the year ended March 2025 as against Rs 3998.80 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 1221.00 | 1068.30 | 14 | 4429.50 | 3998.80 | 11 |
| OPM % | 44.89 | 46.55 | - | 49.58 | 43.80 | - |
| PBDT | 604.20 | 533.10 | 13 | 2526.60 | 1860.30 | 36 |
| PBT | 505.90 | 477.60 | 6 | 2291.40 | 1673.50 | 37 |
| NP | 406.60 | 386.30 | 5 | 1885.40 | 1388.30 | 36 |